Form 4 for STIM Neuronetics, Inc.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0001193125-26-096629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | 2026-03-04 | STIM | MACAN WILLIAM ANDREW | EVP, CLO, CS | S - Sale | $1.34 | -609 | 879.5K | -0.1% | -$816.06 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | S | D | 609 | $1.34 | 879,525 | D | — | — | (F1) The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.39 to $1.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |